Meetings: Immunization Practices Advisory Committee,

[Federal Register: January 22, 1999 (Volume 64, Number 14)]

[Notices]

[Page 3522]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr22ja99-80]

[[Page 3522]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Advisory Committee on Immunization Practices: Meeting

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following committee meeting:

Name: Advisory Committee on Immunization Practices (ACIP).

Times and Dates: 9 a.m.-5:45 p.m., February 17, 1999, 8 a.m.- 3:45 p.m., February 18, 1999.

Place: Atlanta Marriott North Central, 2000 Century Boulevard, N.E., Atlanta, Georgia 30345-3377.

Status: Open to the public, limited only by the space available.

Purpose: The Committee is charged with advising the Director, CDC, on the appropriate uses of immunizing agents. In addition, under 42 U.S.C. Sec. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding the appropriate periodicity, dosage, and contraindications applicable to the vaccines.

Matters to be Discussed: The agenda will include an update from the Food and Drug Administration; update from the National Immunization Program; update from the Vaccine Injury Compensation Program; update from the National Vaccine Program; update from the pneumococcal working group; report by the polio working group on transition to an all Inactivated Poliovirus schedule; prevention and control of influenza recommendation; world and U.S. influenza surveillance data for the 1999-2000 season; influenza-related morbidity in young children; 1999 influenza vaccine guidelines; prevention of varicella; varicella use in children with HIV/AIDS; update on varicella safety and efficacy; post exposure use of varicella vaccine; ACIP recommendations for vaccination of adults; ACIP recommendations for vaccine requirements for day care and school entry; update on the status of the hepatitis B recommendation; revised recommendation for vaccination of children against hepatitis A; revised recommendation for Lyme disease vaccine; use of rotavirus vaccine in premature children; update on general principles of VFC; consolidating VFC resolutions for pneumococcal, hepatitis A and hepatitis B vaccines; draft recommendation for algorithms for immunization registries; electronic updating of ACIP reports and recommendations; and the anti-vaccine movement in the U.S.A. Other matters of relevance among the committee's objectives may be discussed.

Agenda items are subject to change as priorities dictate.

Contact Person for More Information: Gloria A. Kovach, Committee Management Specialist, CDC, 1600 Clifton Road, NE, m/s D50, Atlanta, Georgia 30333. Telephone 404/639-7250.

The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Dated: January 15, 1999. Carolyn J. Russell, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

[FR Doc. 99-1498Filed1-21-99; 8:45 am]

BILLING CODE 4163-18-P